MoneyWorks4Me

Lupin informs about press release

21 Feb 2025 Evaluate
Lupin has informed that it enclosed a Press Release regarding receipt of Establishment Inspection Report from US FDA for the Company’s manufacturing facility in Somerset, New Jersey, for the inspection conducted from January 27 to January 31, 2025.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..